Frankfurt: The chief executive of GlaxoSmithKline (GSK), the world’s largest maker of vaccines, has expressed the hope that a COVID-19 immunisation will be widely available next year.
“I share the optimism that we will have solutions next year. The challenge here is getting to the scale that is required,” GSK CEO Emma Walmsley said at an online event of the Confederation of British Industry (CBI) on Tuesday, NDTV reported.
Walmsley said that safety was not being compromised to get an early result.
“We are condensing timelines that can take 10 years into two years. But people should feel very reassured that the way we do that is (due to) a completely different level of collaboration with regulators,” the CEO was quoted as saying.
“We are putting our funds at risk, governments have put funds at risk so that we don’t restrict the scale, which is really important in a trial for vaccines,” she added
